Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.
Journal: The New England journal of medicine
Published: November 05, 2025
Na-GST-1 adsorbed on Alhydrogel co-administered with different Toll-like receptor agonists in hookworm-naive adults using a controlled human infection model in the USA: a phase 2, double-blind, randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: October 29, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humans.
Journal: Science (New York, N.Y.)
Published: May 15, 2025
Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults.
Journal: Vaccines
Published: January 14, 2025
Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults.
Journal: PLoS neglected tropical diseases
Published: October 08, 2024
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.
Journal: Research square
Published: May 19, 2023
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.
Journal: Science translational medicine
Published: April 19, 2023
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
Journal: medRxiv : the preprint server for health sciences
Published: July 28, 2022
Translational sciences approach to RSV vaccine development.
Journal: Expert review of vaccines
Published: September 24, 2013
Last Updated: 09/26/2026